|
NCCN Optimizing Patient Outcomes - Hitting the Right Target: Updates in Biomarker-Directed Therapy for Non-Small Cell Lung Cancer |
07/16/2026 - 2:00pm to 3:00pm |
|
NCCN Tumor Boards: New and Emerging Treatment Options for Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer |
07/27/2026 - 2:00pm to 3:00pm |
|
NCCN Tumor Boards: Molecularly Guided Treatment of Adult Gliomas |
08/07/2026 - 2:00pm to 3:00pm |
|
NCCN Optimizing Patient Outcomes - Small Cell Lung Cancer: Is Immunotherapy Moving the Needle? |
09/03/2026 - 1:00pm to 2:00pm |
|
NCCN Tumor Boards: Induction Therapy for Ph+ B-Cell Acute Lymphoblastic Leukemia |
10/08/2026 - 4:30pm to 5:30pm |
|
NCCN Optimizing Patient Outcomes - Management of Bispecific T-Cell Engager Toxicities: How to Balance Increased Efficacy with Notable Toxicity |
10/16/2026 - 10:00am to 11:00am |